STATIN-INDUCED EPIGENETIC DYSREGULATION CONTRIBUTES TO THE DEVELOPMENT OF TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Galicia, U. [1 ]
Jebari-Benslaiman, S. [1 ]
Larrea, A. [1 ]
Benito, A. [1 ,3 ,4 ]
Civeira, F. [2 ]
Cenarro, A. [5 ]
Martin, C. [1 ]
机构：
[1] Biofisika Inst, Biochem & Mol Biol, Leioa, Spain
[2] Unidad Lipidos & Arterioesclerosis, Lipid Unit, Zaragoza, Spain
[3] Hosp Univ Miguel Servet, CIBERCV, IIS Aragon, Zaragoza, Spain
[4] Univ Zaragoza, Dept Med, Zaragoza, Spain
[5] Hosp Univ Miguel Servet, IIS Aragon, Zaragoza, Spain
来源：
ATHEROSCLEROSIS | 2021年 / 331卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P520
引用
收藏
页码：E221 / E221
页数：1
相关论文
共 50 条
  • [31] Apoptosis contributes to the generation of statin-induced myonecrosis in human skeletal muscle cells
    Ndountse-Tchapda, L
    Schramm, U
    Trommer, WE
    Wolf, A
    DRUG METABOLISM REVIEWS, 2004, 36 : 229 - 229
  • [32] Statin therapy is associated with epigenetic modifications in individuals with type 2 diabetes
    Schrader, Silja
    Perfilyev, Alexander
    Martinell, Mats
    Garcia-Calzon, Sonia
    Ling, Charlotte
    EPIGENOMICS, 2021, 13 (12) : 919 - 925
  • [33] Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization study
    Smit, Roelof A. J.
    Trompet, Stella
    Leong, Aaron
    Goodarzi, Mark O.
    Postmus, Iris
    Warren, Helen
    Theusch, Elizabeth
    Barnes, Michael R.
    Arsenault, Benoit J.
    Li, Xiaohui
    Feng, QiPing
    Chasman, Daniel, I
    Cupples, L. Adrienne
    Hitman, Graham A.
    Krauss, Ronald M.
    Psaty, Bruce M.
    Rotter, Jerome, I
    le Cessie, Saskia
    Stein, C. Michael
    Jukema, J. Wouter
    PHARMACOGENOMICS JOURNAL, 2020, 20 (03): : 462 - 470
  • [34] Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization study
    Roelof A. J. Smit
    Stella Trompet
    Aaron Leong
    Mark O. Goodarzi
    Iris Postmus
    Helen Warren
    Elizabeth Theusch
    Michael R. Barnes
    Benoit J. Arsenault
    Xiaohui Li
    QiPing Feng
    Daniel I. Chasman
    L. Adrienne Cupples
    Graham A. Hitman
    Ronald M. Krauss
    Bruce M. Psaty
    Jerome I. Rotter
    Saskia le Cessie
    C. Michael Stein
    J. Wouter Jukema
    The Pharmacogenomics Journal, 2020, 20 : 462 - 470
  • [35] The metabolic-epigenetic nexus in type 2 diabetes mellitus
    Davison, Gareth W.
    Irwin, Rachelle E.
    Walsh, Colum P.
    FREE RADICAL BIOLOGY AND MEDICINE, 2021, 170 : 194 - 206
  • [36] Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus
    Hossan, Tareq
    Kundu, Shoumik
    Alam, Sayeda Sadia
    Nagarajan, Sankari
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2019, 19 (06) : 775 - 786
  • [37] Current Genetic and Epigenetic Insights into Type 2 Diabetes Mellitus
    Alaml, Fahmida
    Kamal, Mohammad A.
    Islam, Md. Asiful
    Banu, Shaheena
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2019, 19 (06) : 717 - 718
  • [38] DNA Methylation: An Epigenetic Insight into Type 2 Diabetes Mellitus
    Alam, Fahmida
    Islam, Md. Asiful
    Gan, Siew Hua
    Mohamed, Mafauzy
    Sasongko, Teguh Haryo
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (28) : 4398 - 4419
  • [39] GENETICS Epigenetic mechanisms underlying type 2 diabetes mellitus
    Hanson, Mark A.
    Godfrey, Keith M.
    Nature Reviews Endocrinology, 2015, 11 (05) : 261 - +
  • [40] Epigenetic mechanisms in the development of type 2 diabetes
    Pinney, Sara E.
    Simmons, Rebecca A.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2010, 21 (04): : 223 - 229
12345